A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug ...

Epithelial ovarian cancer is the fourth biggest cause of cancer-related death in women. Over recent decades, improvements have been made in treatment outcome in terms of response rate and survival.

But what if they could prevent the spread of cancer altogether? Well, that’s precisely what OvarianVax, the world’s first ovarian cancer prevention vaccine, strives to do. Researchers at the ...

HRD is now used as a biomarker for administering PARP inhibitors or platinum-based chemotherapy (such as cisplatin or carboplatin) to ovarian cancer patients. PARP inhibitors, which are now used ...

Neoadjuvant chemotherapy for advanced ovarian cancer was initially administered as an alternative treatment for patients not suitable for primary debulking surgery (PDS) because of unresectable ...

Surgery is also recommended if there's any concern an ovarian cyst could be cancerous, or if a person has other risk factors for ovarian cancer. Ovarian cysts often go away on their own but in some ...

Dec. 19, 2024 — There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If ... Researchers Discover ...

DelveInsight's Germ Cell Tumors Market Insights report includes a comprehensive understanding of current treatment practices, ...

Frank Berger, for instance, was working on a preservative for penicillin in 1945 when he noted that when rats were given one ...

Alkylating agents are common chemotherapy medicines that help keep cancer cells from multiplying. They're used to treat different cancers, such as lung, breast, and ovarian cancers, as well as ...